These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 2408735

  • 1. A randomized prospective comparison of methotrexate with a combination of methotrexate, bleomycin, and cisplatin in head and neck cancer.
    Vogl SE, Schoenfeld DA, Kaplan BH, Lerner HJ, Engstrom PF, Horton J.
    Cancer; 1985 Aug 01; 56(3):432-42. PubMed ID: 2408735
    [Abstract] [Full Text] [Related]

  • 2. Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck. A phase III study of the EORTC Head and Neck Cancer Cooperative Group.
    Clavel M, Vermorken JB, Cognetti F, Cappelaere P, de Mulder PH, Schornagel JH, Tueni EA, Verweij J, Wildiers J, Clerico M.
    Ann Oncol; 1994 Jul 01; 5(6):521-6. PubMed ID: 7522527
    [Abstract] [Full Text] [Related]

  • 3. Treatment of recurrent head and neck cancer with cisplatin and 5-fluorouracil vs. the same plus bleomycin and methotrexate.
    Amrein PC, Fabian RL.
    Laryngoscope; 1992 Aug 01; 102(8):901-6. PubMed ID: 1379664
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of the combination of cis-platinum, oncovin and bleomycin (COB) versus methotrexate in patients with advanced squamous cell carcinoma of the head and neck.
    Drelichman A, Cummings G, Al-Sarraf M.
    Cancer; 1983 Aug 01; 52(3):399-403. PubMed ID: 6190548
    [Abstract] [Full Text] [Related]

  • 5. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Gebbia V, Valenza R, Testa A, Borsellino N, Cannata G, Restivo S, Speciale R, Ingria F, Spadafora G, Gebbia N.
    ORL J Otorhinolaryngol Relat Spec; 1994 Aug 01; 56(5):279-82. PubMed ID: 7526312
    [Abstract] [Full Text] [Related]

  • 6. Combination chemotherapy with methotrexate, bleomycin, and vincristine with or without cisplatin in advanced squamous cell carcinoma of the head and neck.
    Clavel M, Cognetti F, Dodion P, Wildiers J, Rosso R, Rossi A, Gignoux B, Van Rymenant M, Cortes-Funes H, Dalesio O.
    Cancer; 1987 Sep 15; 60(6):1173-7. PubMed ID: 2441836
    [Abstract] [Full Text] [Related]

  • 7. A randomized study of methotrexate, bleomycin, hydroxyurea with versus without cisplatin in patients with previously untreated and recurrent squamous cell carcinoma of the head and neck.
    Abele R, Honegger HP, Grossenbacher R, Mermillod B, Kaplan E, Gervasi A, Wolfensberger M, Lehmann W, Cavalli F.
    Eur J Cancer Clin Oncol; 1987 Jan 15; 23(1):47-53. PubMed ID: 2439344
    [Abstract] [Full Text] [Related]

  • 8. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L, Gravenor D, Black M, Frenkiel S, Margolese R.
    Cancer Treat Rep; 1985 Sep 15; 69(9):1015-7. PubMed ID: 2411401
    [Abstract] [Full Text] [Related]

  • 9. Mitomycin-C, methotrexate, bleomycin and cis-diamminedichloroplatinum II in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE, Lerner H, Kaplan BH, Camacho F, Cinberg J, Schoenfeld D.
    Cancer; 1982 Jul 01; 50(1):6-9. PubMed ID: 6177393
    [Abstract] [Full Text] [Related]

  • 10. Recurrent and/or metastatic head and neck squamous cell carcinoma: a clinical, univariate and multivariate analysis of response and survival with cisplatin-based chemotherapy.
    Recondo G, Armand JP, Tellez-Bernal E, Domenge C, Belehradek M, De Vathaire F, Wibault P, Richard JM, Cvitkovic E.
    Laryngoscope; 1991 May 01; 101(5):494-501. PubMed ID: 1709437
    [Abstract] [Full Text] [Related]

  • 11. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P, Dodion PF, Andry G, Chantrain G, Dor P, Buyse M, Van Houtte P, Lemort M, Haesendonck P, Larsimont D.
    Eur J Surg Oncol; 1989 Dec 01; 15(6):568-74. PubMed ID: 2480922
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate.
    Williams SD, Velez-Garcia E, Essessee I, Ratkin G, Birch R, Einhorn LH.
    Cancer; 1986 Jan 01; 57(1):18-23. PubMed ID: 2416423
    [Abstract] [Full Text] [Related]

  • 13. Chemotherapy of squamous head and neck cancer: a prospective randomized trial comparing cis-platinum and bleomycin with methotrexate and vindesine.
    von Heyden HW, Schröder M, Scherpe A, Borghardt J, Beyer JH, Nagel GA, Gerhartz H, Foth B, Kastenbauer E, Westerhausen M.
    Recent Results Cancer Res; 1985 Jan 01; 98():148-52. PubMed ID: 2412266
    [No Abstract] [Full Text] [Related]

  • 14. [Randomized study of cisplatin-based combination chemotherapy for the treatment of planocellular cancer of the head and neck region].
    Olasz L, Németh A, Nyárády Z, Tornóczky T, Királyfalvi L.
    Orv Hetil; 2000 Nov 05; 141(45):2433-7. PubMed ID: 11111384
    [Abstract] [Full Text] [Related]

  • 15. [Chemotherapy or chemotherapy and radiotherapy in advanced head and neck tumors. A prospective, randomized study comparing the 2 therapeutic modalities].
    Klima A, von Ilberg C, Bergmann L, Zoubek A, Klippstein T, Mitrou PS, Szepesi S.
    HNO; 1987 Feb 05; 35(2):78-83. PubMed ID: 2437086
    [Abstract] [Full Text] [Related]

  • 16. Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study.
    Paccagnella A, Pappagallo GL, Segati R, Zorat P, Cavaniglia G, Lunghi F, Migliorini V, Frattina A, Bianco A, Sileni VC.
    Eur J Cancer; 1993 Feb 05; 29A(5):704-8. PubMed ID: 7682427
    [Abstract] [Full Text] [Related]

  • 17. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR.
    J Natl Cancer Inst; 1992 Jun 03; 84(11):877-82. PubMed ID: 1375657
    [Abstract] [Full Text] [Related]

  • 18. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA, Metch B, Schuller DE, Ensley JF, Hutchins LF, Triozzi P, Kish JA, McClure S, VonFeldt E, Williamson SK.
    J Clin Oncol; 1992 Aug 03; 10(8):1245-51. PubMed ID: 1634913
    [Abstract] [Full Text] [Related]

  • 19. Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck.
    Vogl SE, Komisar A, Kaplan BH, Engstrom PF, Kasule OH, Stolbach L, Lerner H, Muggia F.
    Cancer; 1986 Feb 15; 57(4):706-10. PubMed ID: 2417680
    [Abstract] [Full Text] [Related]

  • 20. Continuous intravenous infusion combination chemotherapy for head and neck squamous cell carcinoma.
    Gonzalez MF, Valdivieso JG, Sartiano GP.
    Oncology; 1984 Feb 15; 41(6):377-82. PubMed ID: 6209601
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.